If you or a loved one suffers from Type II diabetes, there’s a strong chance you’ve been prescribed or offered an SLGT2 Inhibitor like Invokana — a drug which works to lower blood glucose levels.
While effective at lowering blood sugar levels, Invokana has been linked to a number of serious side effects — most notable being amputations in the lower extremities.
Two clinical studies — CANVAS and CANVAS-R — showed there was some link between patients who used the drug and an increased risk of lower extremity amputations-toes, foot and leg.
FDA Issues warnings about Invokana
The FDA has issued multiple warnings on Invokana — first in 2015 when the FDA found the first links between Invokana and ketoacidosis when it reviewed dozens of reports of patients who took the drug and required hospitalization. Later that year the FDA revised the label on Invokana to warn those who were prescribed it could suffer from brittle bones.
In June 2016 it was found the drug was linked to acute kidney injuries which required hospitalization. Again in 2017, a black box warning (The FDA’s strongest warning) was added to alert patients to contact their doctors immediately if they experienced sores, pain, inflammation or signs of infection in the lower leg, foot or toes.
Do you have an Invokana Lawsuit?
Janssen, a parent company of Johnson & Johnson, is responsible for the production of Invokana and the potentially misleading information about the risks it poses to their patients. If you or your loved one have had to amputate part of your lower leg after taking Invokana for your type II diabetes, you may be entitled to financial compensation for your injuries.
Walton Telken is currently resolving cases for clients who believe they have lost a lower part of their leg and/or foot from taking Invokana. Contact Stephanie Lyons at (618) 272-2284 for your free consultation about any personal injury or wrongful death you believe was associated with your type II diabetes and Invokana prescription.
